GlaxoSmithKline (GSK) CEO, Emma Walmsley on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/03/21
GlaxoSmithKline Shares Slip On Weaker Profit Forecast For 2021, Plans To Cut DividendBenzinga • 02/03/21
GSK and CureVac are making 'next-generation' vaccines that they say can tackle multiple COVID-19 variants at onceBusiness Insider • 02/03/21
GSK and CureVac join forces to develop vaccines targeting new COVID-19 variantsMarket Watch • 02/03/21
Pfizer, GSK-Backed ViiV First To Get FDA Approval For Injectable Drug To Treat HIVBenzinga • 01/22/21